CODX Historical Income Statement
| CODX Stock | USD 0.73 0.00 0.000003% |
Historical analysis of Co Diagnostics income statement accounts such as Selling General Administrative of 15 M, Total Revenue of 6.5 M or Gross Profit of 2.5 M can show how well Co Diagnostics performed in making a profits. Evaluating Co Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Co Diagnostics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Co Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Co Diagnostics is a good buy for the upcoming year.
CODX |
About CODX Income Statement Analysis
Co Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Co Diagnostics shareholders. The income statement also shows CODX investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Co Diagnostics Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Co Diagnostics minus its cost of goods sold. It is profit before Co Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Co Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Co Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.At this time, Co Diagnostics' Non Operating Income Net Other is fairly stable compared to the past year.
Co Diagnostics income statement Correlations
Click cells to compare fundamentals
Co Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Co Diagnostics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 106.4K | 175.0 | 473.5K | 14.9M | 17.1M | 18.0M | |
| Selling General Administrative | 3.5M | 8.3M | 11.6M | 14.3M | 14.3M | 15.0M | |
| Total Revenue | 215.0K | 74.6M | 97.9M | 34.2M | 6.8M | 6.5M | |
| Gross Profit | 102.5K | 58.0M | 86.3M | 28.7M | 2.6M | 2.5M | |
| Operating Income | (5.9M) | 41.7M | 46.1M | (11.6M) | (42.7M) | (40.6M) | |
| Net Income From Continuing Ops | (6.2M) | 42.5M | 36.7M | (14.2M) | (42.6M) | (40.4M) | |
| Ebit | (5.9M) | 41.7M | 46.1M | (11.6M) | (42.7M) | (40.6M) | |
| Research Development | 1.4M | 3.2M | 15.0M | 17.4M | 23.0M | 24.1M | |
| Cost Of Revenue | 112.4K | 16.6M | 11.6M | 5.5M | 4.2M | 4.2M | |
| Total Operating Expenses | 6.0M | 16.3M | 40.2M | 40.3M | 44.1M | 46.3M | |
| Income Before Tax | (6.2M) | 42.6M | 45.6M | (18.8M) | (38.1M) | (36.2M) | |
| Total Other Income Expense Net | (301.8K) | 875.4K | (429.2K) | 8.1M | 4.6M | 4.8M | |
| Net Income Applicable To Common Shares | (6.2M) | 42.5M | 36.7M | (14.2M) | (16.4M) | (15.6M) | |
| Net Income | (6.1M) | 42.5M | 36.7M | (14.2M) | (35.3M) | (33.6M) | |
| Income Tax Expense | (126.4K) | 90.5K | 9.0M | (4.6M) | (2.8M) | (2.6M) | |
| Interest Income | 36.7K | 97.2K | 45.6K | 704.0K | 1.0M | 1.1M | |
| Depreciation And Amortization | (130.3K) | 138.6K | 335.4K | 1.3M | 1.2M | 1.3M | |
| Selling And Marketing Expenses | 1.1M | 4.7M | 13.4M | 7.3M | 6.9M | 4.3M | |
| Other Operating Expenses | 6.1M | 32.9M | 51.8M | 45.8M | 49.5M | 52.0M | |
| Ebitda | (6.0M) | 41.8M | 46.4M | (10.3M) | (41.5M) | (39.4M) | |
| Net Interest Income | (69.8K) | 97.2K | 45.6K | 704.0K | 1.0M | 1.1M | |
| Reconciled Depreciation | 65.9K | 138.6K | 335.4K | 1.3M | 1.2M | 1.3M | |
| Non Operating Income Net Other | (301.8K) | 875.4K | (429.2K) | 8.1M | 9.4M | 9.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.